Thrombolytic medicine market keeps expanding worldwide, bringing rising
demand for pharmaceutical-grade urokinase raw materials. Choosing a trustworthy
Urokinase manufacturer directly influences drug quality, registration progress
and clinical safety. Urokinase, extracted from human urine, is an important
serine protease widely used for thrombus treatment in injectable preparations. A
qualified Urokinase manufacturer must strictly control specific activity,
endotoxin and microbial limits of the API.
Kangyuan is a reliable Urokinase manufacturer based in Qingdao. We adopt
advanced purification technology to obtain high-specific-activity urokinase, and
run GMP standardized production. Independent quality control laboratory carries
out full item detection for each batch of urokinase API. Complete production
records are reserved for audit and traceability.
Many international pharmaceutical purchasers encounter problems such as
unstable enzyme activity, high impurity content and incomplete supporting
documents. Substandard urokinase API may affect drug curative effect and trigger
safety hazards. As a professional Urokinase manufacturer, we provide
comprehensive certification documents to support overseas drug registration and
factory audit.
We can supply samples for laboratory research, and deliver bulk raw
materials for commercial production. Cold chain logistics options are available
to maintain enzyme activity during cross-border shipment. Our technical team can
answer questions related to product specifications, storage condition and
application suggestions.
We keep optimizing our purification process to improve product stability
and reduce batch difference. Whether you need raw materials for new drug
research or mass production, you can contact Kangyuan to get sample information
and supply quotation.